The abstract explicitly states that the significance of glial inclusions in disease pathogenesis remains unclear. Determining whether these inclusions are pathogenic drivers or downstream consequences is critical for understanding disease mechanisms and identifying therapeutic targets. Gap type: open_question Source paper: Tau-positive glial inclusions in progressive supranuclear palsy, corticobasal degeneration and Pick's disease. (1999, Brain pathology (Zurich, Switzerland), PMID:10517506)
Landscape Summary: What role do tau-positive glial inclusions play in disease pathogenesis versus being secondary markers? is a 0.78 priority gap in neurodegeneration. It has 0 linked hypotheses with average composite score 0.000. Status: open.
Colonna, Sevlever, et al. (TREM2 biology)
What role do tau-positive glial inclusions play in disease pathogenesis versus being secondary markers? — INVOKE-2 (completed)
No hypotheses linked to this gap yet.
No knowledge graph edges recorded
No activity recorded yet.
No discussions yet. Be the first to comment.
Create sub-tasks to investigate specific aspects of this gap: